In the past, a number of studies have revealed the deregulation of EPHB6 in a variety of malignancies, including breast cancers, colorectal cancers and pediatric T-cell acute lymphoblastic leukemia, among others [32–34]. This evidence concerns the gene EPHB6 and breast carcinoma.